Glenmorgan Investments

Emerging Technology · Austin, US · Founded 2016

Neuralink

Develops implantable brain-computer interfaces to restore communication and device control.

Neuralink logo
Company profilePrivate

This is a concise directory profile. Glenmorgan has not produced deep-dive research on this company; only verified headline observations are shown.

Historical valuation & funding observations

Only verified observations are shown; this is not a complete funding history or a current valuation. Financial metrics not verified in this dataset are unavailable.

Funding round valuation (reported, pre-money)

$9bn

Media report

Source: Reuters · 27 May 2025

Source announcements

  • Neuralink raises $650m in latest funding round

    2 Jun 2025

Related companies

Neuralink / Access & terms

Know the terms before you commit.

This is company research, not a verified investment offer. No company-specific allocation, eligibility, fees or holding terms have been confirmed for an opportunity on this website.

Secondary-market access: Not confirmed

Opportunity name
Please contact a representative for current terms
Investment type: pre-IPO, IPO or other
Please contact a representative for current terms
Eligibility requirements
Please contact a representative for current terms
Allocation status
Please contact a representative for current terms
Secondary-market availability
Not confirmed
Minimum holding period
Please contact a representative for current terms
Reinvestment requirements
Please contact a representative for current terms
Applicable fee structure
Please contact a representative for current terms
Terms last reviewed
Please contact a representative for current terms

Relevant risks and restrictions: Capital loss, limited liquidity, uncertain listing, valuation uncertainty, transfer restrictions and required approvals. Product-specific restrictions remain unconfirmed. A historical tender or financing does not establish current secondary access.

Review eligibility

The Glenmorgan Private Markets Briefing

The Glenmorgan Private Markets Briefing

Stay informed on private-company research, funding announcements and historical valuations.

The newsletter is free. Read published editions; email delivery is not connected yet.